Annual report pursuant to Section 13 and 15(d)

Intangibles (Narrative) (Details)

v3.21.1
Intangibles (Narrative) (Details)
 1 Months Ended 12 Months Ended
Jan. 01, 2022
USD ($)
Jul. 01, 2021
USD ($)
Apr. 01, 2021
USD ($)
Jan. 01, 2021
USD ($)
Dec. 18, 2020
USD ($)
installment
Jun. 29, 2020
USD ($)
Milestone
Jul. 22, 2019
USD ($)
Milestone
Aug. 31, 2018
Jan. 31, 2016
USD ($)
Mar. 31, 2015
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2016
USD ($)
Dec. 31, 2018
USD ($)
Finite-Lived Intangible Assets [Line Items]                                
Installment payment related to intangible asset                         $ 500,000 $ 0    
Amortization of intangible assets                         1,420,000 1,174,000    
Intangible asset, net                         14,629,000 7,377,000   $ 1,417,000
Purchase of intangible asset                         1,200,000 2,400,000    
Anti-itch Product [Member]                                
Finite-Lived Intangible Assets [Line Items]                                
Total consideration         $ 4,000,000.0                      
Asset purchase agreement, non refundable deposit         $ 200,000                      
Installment payment related to intangible asset       $ 1,800,000                        
Number of installments to pay the upfront fees | installment         3                      
Amortization of intangible assets                         0      
Initial discount for imputed interest         $ 100,000                      
Intangible assets, estimated useful lives         3 years                      
Anti-itch Product [Member] | Scenario, Plan [Member]                                
Finite-Lived Intangible Assets [Line Items]                                
Installment payment related to intangible asset $ 1,000,000.0 $ 500,000 $ 500,000               $ 1,000,000.0 $ 2,800,000        
Oral Acne Product (Isotretinoin) [Member]                                
Finite-Lived Intangible Assets [Line Items]                                
Total consideration           $ 5,000,000.0                    
Installment payment related to intangible asset         $ 3,500,000 500,000                    
Number of installments to pay the upfront fees | installment         3                      
Upfront payment payable           1,000,000.0                    
Amortization of intangible assets                         0      
Initial discount for imputed interest           $ 300,000                    
Intangible assets, estimated useful lives           5 years                    
Oral Acne Product (Isotretinoin) [Member] | Regulatory Approvals to Commercialize the Products [Member]                                
Finite-Lived Intangible Assets [Line Items]                                
Installment payment related to intangible asset           $ 500,000                    
Oral Acne Product (Isotretinoin) [Member] | Upon the Delivery of the First Order [Member]                                
Finite-Lived Intangible Assets [Line Items]                                
Installment payment related to intangible asset           500,000                    
Oral Acne Product (Isotretinoin) [Member] | Anniversary of Execution of the Oral Acne Agreement [Member]                                
Finite-Lived Intangible Assets [Line Items]                                
Installment payment related to intangible asset           3,000,000.0                    
Oral Acne Product (Isotretinoin) [Member] | On the 18-month Anniversary [Member]                                
Finite-Lived Intangible Assets [Line Items]                                
Installment payment related to intangible asset           1,000,000.0                    
Oral Acne Product (Isotretinoin) [Member] | On the 24-month Anniversary [Member]                                
Finite-Lived Intangible Assets [Line Items]                                
Installment payment related to intangible asset           1,000,000                    
Oral Acne Product (Isotretinoin) [Member] | On the 36-month Anniversary [Member]                                
Finite-Lived Intangible Assets [Line Items]                                
Installment payment related to intangible asset           1,000,000                    
Oral Acne Product (Isotretinoin) [Member] | Achievement of Certain Sales Milestones [Member]                                
Finite-Lived Intangible Assets [Line Items]                                
Installment payment related to intangible asset           $ 17,000,000.0                    
Number of installments to pay the upfront fees | Milestone           3                    
Luxamend [Member]                                
Finite-Lived Intangible Assets [Line Items]                                
Upfront payment payable                 $ 50,000              
Upfront fees payment                             $ 300,000  
Intangible assets, estimated useful lives                             3 years  
Targadox [Member]                                
Finite-Lived Intangible Assets [Line Items]                                
Upfront fees payment                   $ 1,300,000            
Ximino [Member]                                
Finite-Lived Intangible Assets [Line Items]                                
Total consideration             $ 9,400,000                  
Installment payment related to intangible asset             $ 7,000,000.0                  
Number of installments to pay the upfront fees | Milestone             4                  
Upfront payment payable             $ 2,400,000                  
Intangible asset, net                         5,690,000 $ 7,100,000    
Initial discount for imputed interest             $ 2,300,000                  
Intangible assets, estimated useful lives             7 years                  
Exelderm [Member]                                
Finite-Lived Intangible Assets [Line Items]                                
Intangible asset, net                         $ 267,000      
Intangible assets, estimated useful lives               3 years